Trial Profile
An Open-Label Treatment Protocol for the Use of Voraxaze as Adjunctive Treatment for Patients Experiencing or at Risk of Methotrexate Toxicity
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Glucarpidase (Primary)
- Indications Chemotherapy-induced damage
- Focus Expanded access; Therapeutic Use
- Sponsors BTG International
- 07 Feb 2015 New trial record